Literature DB >> 11796363

Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000).

Teresa M Coque1, Antonio Oliver, José Claudio Pérez-Díaz, Fernando Baquero, Rafael Cantón.   

Abstract

Over a 12-year period (1989 to 2000), 159 Klebsiella pneumoniae isolates harboring extended-spectrum beta-lactamases (ESBLs) (4.8% of the total number of K. pneumoniae isolates obtained) were recovered from 58 patients, who were mainly hospitalized in intensive care and surgery units. For 62 representative isolates from 58 patients, 31 clonal types harboring TEM-4 (n = 5), SHV-2 (n = 7), SHV2a (n = 4), SHV-5 (n = 1), CTX-M-10 (n = 13), or CTX-M-9 (n = 1) beta-lactamases were identified by pulsed-field gel electrophoresis. This is the first report to document the presence of the CTX-M-10 or the CTX-M-9 beta-lactamase in K. pneumoniae. These beta-lactamases were previously identified in Escherichia coli isolates from Spain. Only two of five K. pneumoniae TEM-4 clones caused more than a single case of infection, with one of them spreading for 9 months. A single plasmid was detected among these TEM-4 clones. Only two of seven K. pneumoniae clones containing SHV-2 and three of four strains harboring SHV-2a were detected in more than one case of infection. Plasmids encoding SHV-2 or SHV-2a were unrelated. Four of 13 K. pneumoniae CTX-M-10 clones were found in more than one patient, with two of them recovered 2 and 5 years apart. As in the case of the SHV-2 isolates, we were unable to document a common transmissible genetic element that could explain the polyclonal structure of our isolates. Nevertheless, the spread of a single gene may be suggested by the presence of a conserved set of noncoding polymorphisms in the sequences. Most ESBL-producing K. pneumoniae clones were ephemeral, being poorly selected and maintained in the hospital setting, but the genes encoding ESBL persisted successfully over the years that the strains were recovered, probably as a minority gene population in the hospital metagenome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796363      PMCID: PMC127031          DOI: 10.1128/AAC.46.2.500-510.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

1.  Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya.

Authors:  S Kariuki; J E Corkill; G Revathi; R Musoke; C A Hart
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  Properties of plasmids responsible for production of extended-spectrum beta-lactamases.

Authors:  G A Jacoby; L Sutton
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

3.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

4.  Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital.

Authors:  A Pałucha; B Mikiewicz; W Hryniewicz; M Gniadkowski
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Two improved promoter sequences for the beta-lactamase expression arising from a single base-pair substitution.

Authors:  S T Chen; R C Clowes
Journal:  Nucleic Acids Res       Date:  1984-04-11       Impact factor: 16.971

7.  Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

Authors:  J Wiener; J P Quinn; P A Bradford; R V Goering; C Nathan; K Bush; R A Weinstein
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

Review 8.  Trends in beta-lactam resistance among Enterobacteriaceae.

Authors:  P Nordmann
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

9.  Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.

Authors:  P A Bradford; C E Cherubin; V Idemyor; B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

10.  Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals.

Authors:  G Arlet; M Rouveau; I Casin; P J Bouvet; P H Lagrange; A Philippon
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

View more
  69 in total

1.  Identification of TEM-10 beta-lactamase in a Kluyvera sp. and other Enterobacteriaceae at a Portuguese hospital.

Authors:  A Duarte; N Faria; T Conceição; M Correia; L M Lito; J Melo Cristino; M J Salgado; R Tenreiro
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

Review 2.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

3.  Detection of CMY-2, CTX-M-14, and SHV-12 beta-lactamases in Escherichia coli fecal-sample isolates from healthy chickens.

Authors:  Laura Briñas; Miguel Angel Moreno; Myriam Zarazaga; Concepción Porrero; Yolanda Sáenz; María García; Lucas Dominguez; Carmen Torres
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  Survey of plasmid-associated genetic markers in enterobacteriaceae with reduced susceptibilities to cephalosporins.

Authors:  Karen E Preston; Eileen M Graffunder; Ann M Evans; Richard A Venezia
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

5.  High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.

Authors:  Monica Cartelle; Maria del Mar Tomas; Francisca Molina; Rita Moure; Rosa Villanueva; German Bou
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

6.  Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

Authors:  Jesús Rodríguez-Baño; Maria Dolores Navarro; Luisa Romero; Luis Martínez-Martínez; Miguel A Muniain; Evelio J Perea; Ramón Pérez-Cano; Alvaro Pascual
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

7.  Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain.

Authors:  Aránzazu Valverde; Teresa M Coque; M Paz Sánchez-Moreno; Azucena Rollán; Fernando Baquero; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Monitoring and characterization of extended-spectrum beta-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003.

Authors:  Laura Briñas; Miguel Angel Moreno; Tirushet Teshager; Yolanda Sáenz; María Concepción Porrero; Lucas Domínguez; Carmen Torres
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

9.  Salmonella enterica serovar infantis producing a CTX-M-9 beta-lactamase.

Authors:  Emilio Valverde Romero; Trinidad Parras Padilla; M Inmaculada García García; Nuria Delgado Ronda; Ana Herrero; Juan Luis Muñoz Bellido; José Angel García Rodríguez
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

10.  High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients.

Authors:  Aránzazu Valverde; Fabio Grill; Teresa M Coque; Vicente Pintado; Fernando Baquero; Rafael Cantón; Javier Cobo
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.